Indications and results of radium 224 (thorium X) therapy of ankylosing spondylitis
Koch, W.
Zeitschrift für Orthopadie und ihre Grenzgebiete 116(4): 608-616
1978
ISSN/ISBN: 0044-3220 PMID: 100981 Document Number: 126773
Document emailed within 1 workday
Related Documents
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Shalaeva, M.P.; Mordberg, E.L. 1989: A method of determining the levels of uranium, thorium and radium in biological specimens Gigiena Truda i Professional'nye Zabolevaniya (3): 49-51
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Bakker, C.; Hidding, A.; van der Linden, S.; van Doorslaer, E. 1994: Cost effectiveness of group physical therapy compared to individualized therapy for ankylosing spondylitis. A randomized controlled trial Journal of Rheumatology 21(2): 264-268
Samborski, W.; Sobieska, M.; Mackiewicz, T.; Stratz, T.; Mennet, M.; Müller, W. 1992: Can thermal therapy of ankylosing spondylitis induce an activation of the disease? Zeitschrift für Rheumatologie 51(3): 127-131
Sanli, H.; Ataman, S.; Akay, B.ü N.; Yilmaz, A.; Yildizlar, D.; Gürgey, E. 2007: Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy Journal of Drugs in Dermatology: Jdd 6(8): 834-836
Harrison, R.A. 1981: Tolerance of pool therapy by ankylosing spondylitis patients with low vital capacities PhysioTherapy 67(10): 296
Mercado, U. 1994: The use of methylprednisolone pulse therapy in a severe case of HLA-B27 negative ankylosing spondylitis Journal of Rheumatology 21(8): 1582-1583
Rosu, O.M.; Ancuta, C. 2015: McKenzie training in patients with early stages of ankylosing spondylitis: results of a 24-week controlled study European Journal of Physical and Rehabilitation Medicine 51(3): 261-268
Menkes, C.J.; Kahan, A.; Feldmann, J.L.; Vinh, T. 1983: Destructive cervical spondylitis. An unusual initial manifestation of ankylosing spondylitis Presse Medicale 12(4): 227-229
Genre, F.; López-Mejías, R.; Miranda-Filloy, J.A.; Carnero-López, B.; Gómez-Acebo, I.és.; Blanco, R.; Ochoa, R.; Rueda, J.; González-Juanatey, C.; Llorca, J.; González-Gay, M.A. 2013: Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy Clinical and Experimental Rheumatology 31(5): 749-755
Tian, Y.-S.; Wang, L.-S.; Wang, X.-Y.; Sun, W.-Q. 2011: Clinical observation on ankylosing spondylitis treated with acupoint catgut embedding combined vessel pricking therapy Zhongguo Zhen Jiu 31(7): 601-604
Appel, H.; Scheer, R.; Haibel, H.; Wu, P.; Spiller, I.; Brandt, H.; Song, I-Ho.; Rudwaleit, M.; Thiel, A.; Sieper, J. 2007: In vitro observations of T cell responsiveness to recall antigens during tumor necrosis factor-alpha-blocking therapy in patients with ankylosing spondylitis Journal of Rheumatology 34(11): 2264-2270
Zochling, J.; Sieper, J.; van der Heijde, Désirée.; Braun, Jürgen.; Weber, U.; Rudwaleit, M.; Leirisalo-Repo, M.; Collantes-Estévez, E.; van der Horst-Bruinsma, I.; Géher, P.; Kvien, T.; deVlam, K.; l Ostergaard, M.; Maksymowych, W. 2008: Development of a core set of domains for data collection in cohorts of patients with ankylosing spondylitis receiving anti-tumor necrosis factor-alpha therapy Journal of Rheumatology 35(6): 1079-1082
Davis, M.J.; Dawes, P.T.; Beswick, E.; Lewin, I.V.; Stanworth, D.R. 1989: Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin British Journal of Rheumatology 28(5): 410-413
Darmawan, J.; Nasution, A.Remy.; Chen, S-Le.; Haq, S.Atiqul.; Zhao, D.; Zeng, Q.; Davatchi, F. 2006: Excellent endpoints from step-down bridge combination therapy of 5 immunosuppressants in NSAID-refractory ankylosing spondylitis: 6 year international study in Asia - WHO-ILAR COPCORD stage II treatment of the autoimmune diseases Journal of Rheumatology 33(12): 2484-2492